T2 Biosystms Stock Today
| TTOO Stock | USD 2.96 0.03 1.00% |
Performance0 of 100
| Odds Of DistressOver 83
|
T2 Biosystms is selling at 2.96 as of the 20th of April 2024; that is -1 percent down since the beginning of the trading day. The stock's open price was 2.99. T2 Biosystms has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for T2 Biosystms are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of June 2022 and ending today, the 20th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 7th of August 2014 | Category Healthcare | Classification Health Care |
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. T2 Biosystems operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 5.51 M outstanding shares of which 396.91 K shares are at this time shorted by private and institutional investors with about 1.91 trading days to cover. More on T2 Biosystms
Moving against TTOO Stock
| 0.68 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
| 0.6 | MRKR | Marker Therapeutics | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
TTOO Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. T2 Biosystms' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding T2 Biosystms or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | John McDonough | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering T2 Biosystms report their recommendations after researching T2 Biosystms' financial statements, talking to executives and customers, or listening in on T2 Biosystms' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering T2 Biosystms. The TTOO consensus assessment is calculated by taking the average forecast from all of the analysts covering T2 Biosystms. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to T2 Biosystms' liquidity, profitability, solvency, and operating efficiency, T2 Biosystms may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of T2 Biosystms is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
T2 Biosystms' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to T2 Biosystms' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand T2 Biosystms' financial leverage. It provides some insight into what part of T2 Biosystms' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
T2 Biosystms (TTOO) is traded on NASDAQ Exchange in USA. It is located in 101 Hartwell Avenue, Lexington, MA, United States, 02421 and employs 113 people. T2 Biosystms is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.48 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate T2 Biosystms's market, we take the total number of its shares issued and multiply it by T2 Biosystms's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. T2 Biosystms conducts business under Biotechnology sector and is part of Health Care industry. The entity has 5.51 M outstanding shares of which 396.91 K shares are at this time shorted by private and institutional investors with about 1.91 trading days to cover.
T2 Biosystms currently holds about 13.21 M in cash with (48.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.87.
Check T2 Biosystms Probability Of Bankruptcy
Ownership AllocationT2 Biosystms shows a total of 5.51 Million outstanding shares. The majority of T2 Biosystms outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to take positions in T2 Biosystms to benefit from reduced commissions. Hence, outside corporations are subject to a different set of regulations than regular investors in T2 Biosystms. Please pay attention to any change in the institutional holdings of T2 Biosystms as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check TTOO Ownership Details
TTOO Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of T2 Biosystms jumping above the current price in 90 days from now is about 88.31%. The T2 Biosystms probability density function shows the probability of T2 Biosystms stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.4737. This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, T2 Biosystms will likely underperform. Additionally, t2 Biosystms has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of T2 Biosystms to move above the current price in 90 days from now is about 88.31 (This T2 Biosystms probability density function shows the probability of TTOO Stock to fall within a particular range of prices over 90 days) .
TTOO Stock Institutional Holders
Institutional Holdings refers to the ownership stake in T2 Biosystms that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of T2 Biosystms' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing T2 Biosystms' value.| Instituion | Recorded On | Shares | |
| Royal Bank Of Canada | 2023-12-31 | 1.3 K | |
| Cwm, Llc Duplicate | 2023-12-31 | 310 | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 120 | |
| Signature Resources Capital Management, Llc | 2023-12-31 | 90.0 | |
| Wells Fargo & Co | 2023-12-31 | 22.0 | |
| Jjj Advisors Inc | 2023-12-31 | 9.0 | |
| U.s. Bancorp | 2023-12-31 | 3.0 | |
| Focused Wealth Strategies, Inc. | 3.0 | ||
| Bank Of America Corp | 0202-12-31 | 2.0 | |
| Susquehanna International Group, Llp | 2023-12-31 | 55 K | |
| Vanguard Group Inc | 2023-12-31 | 45.7 K |
T2 Biosystms Historical Income Statement
T2 Biosystms Income Statement is one of the three primary financial statements used for reporting TTOO's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of T2 Biosystms revenue and expense. T2 Biosystms Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, T2 Biosystms' Total Revenue is very stable compared to the past year. As of the 20th of April 2024, Other Operating Expenses is likely to grow to about 55.3 M, while Depreciation And Amortization is likely to drop about 843.9 K. View More FundamentalsTTOO Stock Against Markets
Picking the right benchmark for T2 Biosystms stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in T2 Biosystms stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for T2 Biosystms is critical whether you are bullish or bearish towards T2 Biosystms at a given time. Please also check how T2 Biosystms' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in T2 Biosystms without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
T2 Biosystms Corporate Directors
T2 Biosystms corporate directors refer to members of a T2 Biosystms board of directors. The board of directors generally takes responsibility for the T2 Biosystms' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of T2 Biosystms' board members must vote for the resolution. The T2 Biosystms board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Harry Wilcox | Independent Director | Profile | |
| Adrian Jones | Director | Profile | |
| Thomas Carella | Independent Director | Profile | |
| Stanley Lapidus | Independent Director | Profile |
How to buy TTOO Stock?
Before investing in T2 Biosystms, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in T2 Biosystms. To buy T2 Biosystms stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of T2 Biosystms. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase T2 Biosystms stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located T2 Biosystms stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased T2 Biosystms stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as T2 Biosystms, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy TTOO Stock please use our How to Invest in T2 Biosystms guide.
Already Invested in T2 Biosystms?
The danger of trading T2 Biosystms is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of T2 Biosystms is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than T2 Biosystms. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile T2 Biosystms is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether T2 Biosystms offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of T2 Biosystms' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of T2 Biosystms Stock. Outlined below are crucial reports that will aid in making a well-informed decision on T2 Biosystms Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in T2 Biosystms. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. To learn how to invest in TTOO Stock, please use our How to Invest in T2 Biosystms guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for TTOO Stock analysis
When running T2 Biosystms' price analysis, check to measure T2 Biosystms' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy T2 Biosystms is operating at the current time. Most of T2 Biosystms' value examination focuses on studying past and present price action to predict the probability of T2 Biosystms' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move T2 Biosystms' price. Additionally, you may evaluate how the addition of T2 Biosystms to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is T2 Biosystms' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of T2 Biosystms. If investors know TTOO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about T2 Biosystms listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (19.19) | Revenue Per Share 2.756 | Quarterly Revenue Growth (0.69) | Return On Assets (0.85) | Return On Equity (6.22) |
The market value of T2 Biosystms is measured differently than its book value, which is the value of TTOO that is recorded on the company's balance sheet. Investors also form their own opinion of T2 Biosystms' value that differs from its market value or its book value, called intrinsic value, which is T2 Biosystms' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because T2 Biosystms' market value can be influenced by many factors that don't directly affect T2 Biosystms' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between T2 Biosystms' value and its price as these two are different measures arrived at by different means. Investors typically determine if T2 Biosystms is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, T2 Biosystms' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.